PMID- 36926233 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230318 IS - 1948-5182 (Print) IS - 1948-5182 (Electronic) VI - 15 IP - 2 DP - 2023 Feb 27 TI - Progressive changes in platelet counts and Fib-4 scores precede the diagnosis of advanced fibrosis in NASH patients. PG - 225-236 LID - 10.4254/wjh.v15.i2.225 [doi] AB - BACKGROUND: Cirrhosis and its complications develop in a subgroup of patients with non-alcoholic fatty liver disease (NASH). Early detection of liver fibrosis represents an important goal of clinical care. AIM: To test the hypothesis that the development of cirrhosis in nonalcoholic fatty liver disease patients is preceded by the long-term trends of platelet counts and Fib-4 scores. METHODS: We identified all patients in our healthcare system who had undergone fibrosis staging by liver biopsy or magnetic resonance elastography (MRE) for non-alcoholic fatty liver disease during the past decade (n = 310). Platelet counts, serum glutamic-pyruvic transaminase and serum glutamic oxalacetic transaminase values preceding the staging tests were extracted from the electronic medical record system, and Fib-4 scores were calculated. Potential predictors of advanced fibrosis were evaluated using multivariate regression analysis. RESULTS: Significant decreases in platelet counts and increases in Fib-4 scores were observed in all fibrosis stages, particularly in patients with cirrhosis. In the liver biopsy group, the presence of cirrhosis was best predicted by the combination of the Fib-4 score at the time closest to staging (P < 0.0001), the presence of diabetes (P = 0.0001), and the correlation coefficient of the preceding time-dependent drop in platelet count (P = 0.044). In the MRE group, Fib4 score (P = 0.0025) and platelet drop (P = 0.0373) were significant predictors. In comparison, the time-dependent rise of the Fib-4 score did not contribute in a statistically significant way. CONCLUSION: Time-dependent changes in platelet counts and Fib-4 scores contribute to the prediction of cirrhosis in NASH patients with biopsy- or MRE-staged fibrosis. Their incorporation into predictive algorithms may assist in the earlier identification of high-risk patients. CI - (c)The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. FAU - Zijlstra, Michael K AU - Zijlstra MK AD - Department of Internal Medicine, NorthShore University Health System, Evanston, IL 60201, United States. FAU - Gampa, Anuhya AU - Gampa A AD - Division of Gastroenterology and Hepatology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637, United States. FAU - Joseph, Nora AU - Joseph N AD - Department of Pathology, NorthShore University Health System, Evanston, IL 60201, United States. FAU - Sonnenberg, Amnon AU - Sonnenberg A AD - Portland VA Medical Center, Portland, OR 97239, United States. AD - Department of Gastroenterology, Oregon Health Sciences University, Portland, OR 97201, United States. FAU - Fimmel, Claus J AU - Fimmel CJ AD - Division of Gastroenterology, Department of Internal Medicine, NorthShore University Health System, Evanston, IL 60201, United States. clausfimmel@att.net. LA - eng PT - Journal Article PL - United States TA - World J Hepatol JT - World journal of hepatology JID - 101532469 PMC - PMC10011908 OTO - NOTNLM OT - Liver biopsy OT - Liver fibrosis OT - Magnetic resonance elastography OT - Non-alcoholic fatty liver disease OT - Prediction OT - cirrhosis COIS- Conflict-of-interest statement: All authors have no conflict of interest to report. EDAT- 2023/03/18 06:00 MHDA- 2023/03/18 06:01 PMCR- 2023/02/27 CRDT- 2023/03/17 02:45 PHST- 2022/06/27 00:00 [received] PHST- 2022/08/02 00:00 [revised] PHST- 2023/01/13 00:00 [accepted] PHST- 2023/03/17 02:45 [entrez] PHST- 2023/03/18 06:00 [pubmed] PHST- 2023/03/18 06:01 [medline] PHST- 2023/02/27 00:00 [pmc-release] AID - 10.4254/wjh.v15.i2.225 [doi] PST - ppublish SO - World J Hepatol. 2023 Feb 27;15(2):225-236. doi: 10.4254/wjh.v15.i2.225.